Immunohistochemistry showed the expression of FAK in both Y15‐treated and control cells, but barely detectable Y397 phosphorylation of FAK in the few residual tumor cells after Y15 treatment (P < 0.001). The gene discussed is PTK2; the disease is neoplasm.